NFKB1 and neoplasm: In the present study, we explored in direct comparison to DON the immunomodulatory effects of NX-3, including its impact on NF-κB signaling pathway activation and on the expression of NF-κB target cytokines in two different intestinal cell lines, comparing the impact on a tumor cell line to noncancer cells.